Arrowhead Pharmaceuticals kompaniyasidagi eng so‘nggi ish o‘rinlari

Arrowhead Pharmaceuticals is a biotechnology company developing RNA interference (RNAi) therapeutics for diseases with limited treatment options. Its medicines use RNA chemistries and delivery technologies to reduce the activity of disease-related genes. The company’s research focuses on cardiometabolic and pulmonary disorders, including conditions such as hypertriglyceridemia, dyslipidemia, cardiovascular disease, and other pulmonary diseases.